Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin

https://doi.org/10.1016/S0960-894X(02)00832-6Get rights and content

Abstract

The quest to find new antitumor compounds is an ongoing research endeavor in many laboratories around the world. The use of small-molecule angiogenesis inhibitors promises to be a potentially effective method for cancer treatment and possible prevention. Many antiangiogenic compounds are in various stages of laboratory evaluations and clinical trials. Curcumin is a natural product that has exhibited potent antiangiogenic properties. Based on a simple pharmacophore model, using standard drug design concepts, aromatic enone and aromatic dienone analogues of curcumin were prepared and/or obtained commercially. These compounds were screened for antiangiogenic properties via an in vitro SVR assay and were found to inhibit cell proliferation.

References (6)

  • J Folkman

    N. Engl. J. Med.

    (1971)
  • J Denekamp

    Cancer Metastasis Rev.

    (1990)
  • J.L Arbiser et al.

    Mol. Med.

    (1998)
There are more references available in the full text version of this article.

Cited by (0)

View full text